載入...
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
OBJECTIVE: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets. ME...
Na minha lista:
| 發表在: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4853553/ https://ncbi.nlm.nih.gov/pubmed/26536893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311475 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|